MARKET: 📊 ETH has an average (mean) growth rate of 4.68% in July.How will it perform this month? https://t.co/4s2RMfp9aW ...

MARKET: 📊 Bitcoin has a median growth rate of 2.2% in July.How will it perform this month? https://t.co/puxsTLDIJf ...

Economists use the real economic growth rate to measure how quickly a country's economy is growing. Learn the difference from the nominal GDP growth rate. https://t.co/X6HN8P9Xqp ...

The stock of Amazon (AMZN -0.94%) has delivered life-changing gains for investors who got in early enough. It's up nearly 200,000% over its lifetime and 900% over the past 10 years.Everyone is talking about what it's doing in artificial intelligence (AI) today and how that could jump-start sales growth. There's a huge long-term opportunity, but can Amazon stock double over the next five years? Growth drivers everywhereWith all of the AI hype, let's not forget that Amazon's main business, for now at least, i ...

reverse DCF for every stock we have a DCF type where if you look at here the DCF type and on this side of DCF type we have the DCF on this side it's a reverse DF model I'm looking at the company brown which I own and for the DCF and the reverse DF there are lots of assumptions the assumptions for example the discount rate what discount rate are And we default to the current 10year treary rate plus 6%. So we default we that's what we default to. So current so that's why it's 11% now the discount rate and the ...

Equifax (EFX) stock has performed well in the past three months. It has gained 8.3% against the industry’s nd the Zacks S&P 500 composite’s 1.3% and 0.8% decline, respectively.EFX reported impressive first-quarter 2025 results. EFX’s adjusted earnings were $1.53 per share, outpacing the Zacks Consensus Estimate by 9.3% and increasing 2% from the year-ago quarter. Total revenues of $1.4 billion surpassed the consensus estimate by 1.9% and grew 3.8% on a year-over-year basis.How is Equifax Faring?EFX’s top li ...

Core Viewpoint - MercadoLibre is positioned as a strong long-term investment in the Latin American e-commerce and fintech sectors, with significant growth potential and favorable market conditions. Group 1: Growth Potential - MercadoLibre operates in 19 Latin American countries, primarily serving customers in Argentina, Brazil, and Mexico, and has room for further expansion [4] - The company has established a logistics network that provides a competitive advantage over rivals like Amazon, allowing it to capture market share early [5] - From 2021 to 2024, MercadoLibre's revenue is projected to grow at a compound annual growth rate (CAGR) of 43%, with over 100 million annual unique active buyers and 60 million fintech monthly active users by the end of 2024 [6] - The Latin American e-commerce market is expected to grow at a CAGR of 16.7% from 2024 to 2030, while the fintech market is projected to expand at a CAGR of 15.9% from 2025 to 2033 [7][8] Group 2: Profitability and Economies of Scale - After a period of unprofitability from 2018 to 2020 due to heavy investments, MercadoLibre returned to profitability in 2021, with net income growing at a CAGR of 185% over the next three years [9][10] - Analysts expect MercadoLibre's earnings per share (EPS) to grow at a CAGR of 34% from 2024 to 2027, driven by higher-margin products and services [10] Group 3: Valuation and Market Position - MercadoLibre's stock trades at approximately $2,579 per share, with a valuation of 52 times this year's earnings and 4.8 times this year's sales, which is reasonable compared to slower-growing competitors like Amazon [12] - With a market capitalization of $131 billion, MercadoLibre remains smaller than e-commerce giants like Amazon and Alibaba, suggesting potential for upside growth [13] - Despite market volatility and macroeconomic concerns, MercadoLibre is considered one of the best growth stocks for long-term investment in the booming e-commerce and fintech markets in Latin America [14]

Core Viewpoint - Companies like Eli Lilly and Visa are positioned to potentially reach a market cap of $1 trillion by 2030, making them attractive long-term investment opportunities due to their growth prospects and market positions [1]. Eli Lilly - Eli Lilly has a current market cap of just under $737 billion and needs a compound annual growth rate (CAGR) of 6.3% to reach $1 trillion by 2030, which is below the market's historical performance [3][4]. - The company faces challenges such as market-wide issues and high valuation metrics, with a forward price-to-earnings (P/E) ratio of 35.4, significantly higher than the healthcare sector average of 16 [3][4]. - Eli Lilly's innovative pipeline includes investigational weight management medicines and a promising gene therapy for deafness, positioning it well in the growing weight loss market [5][7]. - The company has a strong dividend growth history, which can enhance returns for long-term investors [7]. Visa - Visa's market cap is just under $679 billion, requiring a CAGR of 8.1% to achieve a $1 trillion valuation by 2030, which is manageable within equity market standards [8]. - The company benefits from inflation as its fees are transaction-based, potentially increasing revenue during economic fluctuations [8][9]. - Visa has demonstrated resilience during economic downturns, maintaining strong performance despite challenges like the pandemic [9][10]. - The company enjoys a dominant position in the payment technology sector with a strong network effect, making it difficult for competitors to disrupt its market [10]. - Visa has significant growth prospects due to the ongoing shift from cash to credit and debit transactions, as well as the expansion of e-commerce [11].

The domain registry operator runs an evergreen business.VeriSign (VRSN -1.40%) isn't considered a high-growth stock. But over the past three years, the domain registry operator's shares rallied 66% as the S&P 500 advanced 37%. Let's see why this oft-overlooked stock beat the market -- and where it might head over the next three years.A boring but evergreen businessVeriSign operates the authoritative domain name registries for the internet's two most popular top-level domains: .com and .net. It's also the ma ...

Following the company's first-quarter earnings report, shares of Hims & Hers Health (HIMS 5.21%) opened the following day considerably lower, only to sprint higher once trading began. This action is just one example of why the stock is a bit of a divisive name among investors. This can also be seen in its high short interest, which sits above 25%.The stock is up around 108% year to date (as of this writing), while at the same time it's down about 27% from the highs it set earlier this year. Let's take a clo ...